Metabolism Disorder TRIZ Cases

Fermented papaya preparation activates NADPH oxidase to increase reactive oxygen species, enhancing immune response without raising blood glucose levels.

Conjugating GLP-1 peptides with oligomers overcomes short half-life and immunogenicity to enable oral administration.

A rose hip extract and caffeine composition reduces body fat by inhibiting hepatic lipogenesis.

Segmented constructs route antigens to the cytoplasm via translocation domains, bypassing inefficient processing pathways.

Unsaponifiable hemp seed extract inhibits lipid droplet formation and adipocyte differentiation to reduce body weight gain.

Ethanolic Borago officinalis extract reduces body weight and reverses dyslipidemia in obese models.

Novel GLP-1 albumin fusion protein extends circulation half-life via reduced renal clearance.

A veterinary bolus containing anhydrous calcium chloride and effervescent compounds dissolves rapidly in rumen fluid to deliver immediate calcium release.

Fluidized bed granulation creates stable calcium acetate particles, preventing decomposition and improving release profiles.

Crystal form I of sodium urate inhibitor resolves dosage and solubility trade-offs through controlled crystallization and structural optimization.

A master equation model analyzes red blood cell maturation to identify anemia risk factors and differentiate thalassemia-trait from iron-deficiency anemia.

Microneedle patches with glucose-responsive vesicles lower blood sugar without complex pumps.

A dietary formulation combines omega-3 fatty acids with arachidonic acid to provide essential nutrition.

Alpha-oxoacylaminocaprolactam derivatives inhibit cathepsin K while minimizing CYP3A4 activity to prevent drug interactions.

Titanium oxide and a 400-500 nm absorption colorant shield pitavastatin from light, preventing decomposition in scored tablets.

A molecular probe precursor labeled with a positron emission nuclide enables three-dimensional imaging of pancreatic islets.

Novel low-molecular-weight organic amide compounds featuring a naphthyl group attached to multiple rings through carbon or amide bonding.

Undercarboxylated osteocalcin increases pancreatic beta-cell proliferation to address ineffective metabolic syndrome treatments.

A composition of guarana and ginkgo biloba extracts with fruit sugars delivers sustained cognitive enhancement.

Administering a calcium sensing receptor agonist before dialysis attenuates phosphate rebound and reduces cardiovascular mortality risk.

Histidine buffers and trehalose stabilize anti-CLEVER-1 antibodies, preventing chemical denaturation and aggregation during storage.

Recombinant glycosylated insulin polypeptides bind serum lectins to enable glucose-responsive pharmacokinetic profiles.

An LGI3-derived peptide composition targets insulin resistance and pancreatic function to treat diabetes.

A novel thiazole derivative process couples pre-synthesized stable intermediates with alkyl halogen acetate to form key compounds.

Itolizumab targets CD6 to reduce IL-23R production, lowering Th17 inflammation without broad TNF-alpha suppression.

Adjusting fibromodulin concentrations addresses ineffective treatments for disorders linked to excessive or deficient myofibroblast activities.

A medication dosage system adjusts therapy parameters using real-time analyte monitoring data.

Indigo carmine in a buffered solution detects oxygen exposure while maintaining color distinction after autoclaving.

A pharmaceutical composition containing a specific indole amine compound targets liver pathology through mitochondrial protection mechanisms.

Cereal plants modified to downregulate starch synthase II activity accumulate high fructan levels.

Small interfering RNA inhibits galectin-12 expression via RNA interference, improving insulin sensitivity and reducing adiposity.

Crystalline xylose isomerase converts fructose to glucose in the small intestine, preventing malabsorption symptoms.

ZSCAN4 expression identifies rare pancreatic stem cells, enabling isolation from adult tissue despite low spontaneous self-renewal rates.

Engineered bacteria produce therapeutic molecules locally in the gut, avoiding systemic side effects of conventional treatments.

Adenosine subsite binding by specific tankyrase inhibitors resolves consistency and efficiency bottlenecks in generating insulin-producing cells.

Segmenting racemic ketoconazole into the 2S,4R enantiomer reduces P450 enzyme inhibition, allowing higher statin doses without liver toxicity.

Tetra-valent sugar clusters modulate insulin release through receptor binding, resolving hypoglycemia risks from uncontrolled delivery.

Modified PCSK9 peptides trigger antibody production that inhibits LDL receptor degradation, resolving adverse effects from statin therapies.

A composition combining fucoxanthin, caffeine, and ephedrine alkaloids to enhance thermogenic activity.

Buffering and tonicity agents prevent noncovalent aggregation of GLP-1 analogues, ensuring bioactivity under freeze-thaw stress.

Ruminococcus torques polypeptides treat metabolic syndrome and osteoporosis by regulating host metabolism and stimulating bone formation.

Double-acylated GLP-1 derivatives attach protracting moieties to lysine residues, extending duration of action beyond mono-acylated limits.

Sodium stearoyl-2-lactylate emulsifies fat into fine droplets, resolving high production costs from excessive raw material usage.

Segmented super mini inverted proinsulin derivatives resolve synthesis complexity while maintaining stability.

Foreshortened C-domains and targeted amino acid substitutions increase thermal resistance and reduce IGF-1R cross-binding in single-chain insulin analogues.

A recombinant adeno-associated virus vector delivers codon-optimized phenylalanine hydroxylase to hepatocytes.

An emulsifier-free hydrocolloid gel matrix stabilizes amorphous vitamins to prevent gastrointestinal irritation and unpleasant taste.